BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23805635)

  • 1. [Cerebrolysin for acute ischemic stroke].
    iganshina LE; Abakumova TR
    Vestn Ross Akad Med Nauk; 2013; (1):21-9. PubMed ID: 23805635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrolysin for acute ischaemic stroke.
    Ziganshina LE; Abakumova T; Vernay L
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007026. PubMed ID: 28430363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrolysin for acute ischaemic stroke.
    Ziganshina LE; Abakumova T; Vernay L
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD007026. PubMed ID: 27918088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrolysin for acute ischaemic stroke.
    Ziganshina LE; Abakumova T; Kuchaeva A
    Cochrane Database Syst Rev; 2010 Apr; (4):CD007026. PubMed ID: 20393954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrolysin for acute ischaemic stroke.
    Ziganshina LE; Abakumova T
    Cochrane Database Syst Rev; 2015 Jun; (6):CD007026. PubMed ID: 26083192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
    Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
    Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial.
    Ladurner G; Kalvach P; Moessler H;
    J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety profile of Cerebrolysin: clinical experience from dementia and stroke trials.
    Thome J; Doppler E
    Drugs Today (Barc); 2012 Apr; 48 Suppl A():63-9. PubMed ID: 22514795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial.
    Gharagozli K; Harandi AA; Houshmand S; Akbari N; Muresanu DF; Vester J; Winter S; Moessler H
    J Med Life; 2017; 10(3):153-160. PubMed ID: 29075343
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Zhang D; Dong Y; Li Y; Chen J; Wang J; Hou L
    Biomed Res Int; 2017; 2017():4191670. PubMed ID: 28656143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials.
    Bornstein NM; Guekht A; Vester J; Heiss WD; Gusev E; Hömberg V; Rahlfs VW; Bajenaru O; Popescu BO; Muresanu D
    Neurol Sci; 2018 Apr; 39(4):629-640. PubMed ID: 29248999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
    Lang W; Stadler CH; Poljakovic Z; Fleet D;
    Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrolysin and early neurorehabilitation in patients with acute ischemic stroke: a prospective, randomized, placebo-controlled clinical study.
    Stan A; Birle C; Blesneag A; Iancu M
    J Med Life; 2017; 10(4):216-222. PubMed ID: 29362596
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials.
    Guekht A; Vester J; Heiss WD; Gusev E; Hoemberg V; Rahlfs VW; Bajenaru O; Popescu BO; Doppler E; Winter S; Moessler H; Muresanu D
    Neurol Sci; 2017 Oct; 38(10):1761-1769. PubMed ID: 28707130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrolysin: a multi-target drug for recovery after stroke.
    Brainin M
    Expert Rev Neurother; 2018 Aug; 18(8):681-687. PubMed ID: 30004268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrolysin dose-dependently improves neurological outcome in rats after acute stroke: A prospective, randomized, blinded, and placebo-controlled study.
    Zhang L; Chopp M; Lu M; Zhang T; Winter S; Doppler E; Meier D; Chao L; Eapen A; Pabla P; Gang Zhang Z
    Int J Stroke; 2016 Apr; 11(3):347-55. PubMed ID: 26763925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrolysin for functional recovery in patients with acute ischemic stroke: a meta-analysis of randomized controlled trials.
    Wang Z; Shi L; Xu S; Zhang J
    Drug Des Devel Ther; 2017; 11():1273-1282. PubMed ID: 28458521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hope Dies Last-Evidence Again Fails to Support a Neuroprotectant: Cerebrolysin for Acute Ischemic Stroke.
    Bereczki D
    Stroke; 2017 Sep; 48(9):2343-2344. PubMed ID: 28747461
    [No Abstract]   [Full Text] [Related]  

  • 19. [A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke].
    Skvortsova VI; Stakhovskaia LV; Gubskiĭ LV; Shamalov NA; Tikhonova IV; Smychkov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):51-5. PubMed ID: 15559222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.
    Muresanu DF; Heiss WD; Hoemberg V; Bajenaru O; Popescu CD; Vester JC; Rahlfs VW; Doppler E; Meier D; Moessler H; Guekht A
    Stroke; 2016 Jan; 47(1):151-9. PubMed ID: 26564102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.